ATI RN
ATI RN Pharmacology 2023 IV Questions
Extract:
Question 1 of 5
A nurse is assessing a client who is receiving clindamycin. Which of the following findings should the nurse identify as an adverse effect of this medication?
Correct Answer: C
Rationale: Watery diarrhea is a common adverse effect of clindamycin due to disruption of gut flora, potentially leading to C. difficile overgrowth.
Question 2 of 5
A nurse is assessing a client who has hypertension and has started taking lisinopril. Which of the following findings should the nurse report to the provider immediately?
Correct Answer: A
Rationale: Eyelid edema can be a sign of angioedema, a rare but serious side effect of ACE inhibitors like lisinopril, potentially leading to airway obstruction.
Question 3 of 5
A nurse is preparing to administer dextrose 5% in water 350 mL IV to infuse over 3 hr. The drop factor of the manual IV tubing is 10 gtt/mL. The nurse should set the manual IV infusion to deliver how many gtt/min?
Correct Answer: A
Rationale: Calculate: (350 mL * 10 gtt/mL) / (3 hr * 60 min/hr) = 3500 gtt / 180 min ≈ 19.44 gtt/min, rounded to 19.
Question 4 of 5
A nurse is reviewing the medication list of a client who has erectile dysfunction and is requesting a prescription for sildenafil. The nurse should identify that which of the following medications is a contraindication for receiving this medication?
Correct Answer: A
Rationale: Nitroglycerin is commonly used to treat angina and works by dilating blood vessels to increase blood flow to the heart. Concomitant use of sildenafil with nitroglycerin or other nitrates is contraindicated due to the risk of severe hypotension and cardiovascular collapse.
Question 5 of 5
A nurse is reviewing the medical record of a female client who asks about a prescription for alendronate for the treatment of osteoporosis. Which of the following findings should the nurse identify as a safety risk for the client when taking this medication?
Correct Answer: B
Rationale: Immobility can significantly affect bone health and metabolism, leading to osteoporosis or exacerbating existing osteoporosis. Alendronate is generally indicated to treat osteoporosis by increasing bone density, but its effectiveness may be compromised if the patient is severely immobilized.